Cargando…
MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway
Long non-coding RNAs (lncRNAs) have been widely reported to regulate the development and chemoresistance of a variety of tumors. Temozolomide (TMZ) is a first-line chemotherapy for treatment of glioma. However, the effect and the regulatory mechanism of lncRNA MSC-AS1 (MSC-AS1) in TMZ-resistant glio...
Autores principales: | Li, Chong, Feng, Shiyu, Chen, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873112/ https://www.ncbi.nlm.nih.gov/pubmed/33106913 http://dx.doi.org/10.1007/s11010-020-03937-x |
Ejemplares similares
-
Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas
por: Wei, Q.T., et al.
Publicado: (2021) -
MiR‐3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway
por: Kong, Shiqi, et al.
Publicado: (2020) -
Long non‐coding RNA HCG11 modulates glioma progression through cooperating with miR‐496/CPEB3 axis
por: Chen, Yangzong, et al.
Publicado: (2019) -
Involvement of PI3K Pathway in Glioma Cell Resistance to Temozolomide Treatment
por: Zając, Adrian, et al.
Publicado: (2021) -
miR-181d promotes cell proliferation via the IGF1/PI3K/AKT axis in glioma
por: Tang, Dong, et al.
Publicado: (2020)